Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 4,147 shares at $216.33 ($897K) on 2021-01-07, disclosed to the SEC on 2021-01-08.
Open-market sale of $897k MRTX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $215.31 | 9 | $2K | 0.2% |
| 2 | $216.33 | 2,069 | $448K | 49.9% |
| 3 | $216.33 | 2,069 | $448K | 49.9% |
| Total | $216.33 avg | 4,147 | $897K | 100% |
| Filing → |
| MRTX | SELL | 2024-01-09 | $246K | — | Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $66K | — | Filing → |